Archive · 12 Aug 2025
Alkem to Expand Non-US Business, Establish Saudi Subsidiary
Alkem, a drug company, plans to grow its business outside the United States.
They are focusing on expanding in other countries and building up their presence in markets with high potential.
The company's revenue increased and the net profit also jumped up.
They are also starting a new branch in Saudi Arabia to sell medicines and health products.
This new branch will be set up within a year.
Alkem is focusing on expanding its non-US business.
The company is establishing a subsidiary in Saudi Arabia.
Total revenue increased by 11.2% to ₹3,371 crore.
Net profit rose by 21.8% to ₹664 crore.
The Saudi Arabian subsidiary will operate in pharma and nutraceuticals.
- Who
- Alkem, a drug company.
- What
- Alkem is accelerating its non-US business and establishing a subsidiary in Saudi Arabia.
- When
- The announcement was made after the company announced its financial performance for the first quarter ended June 30.
- Where
- Saudi Arabia.
- Why
- To expand the company’s business and market reach.
- Total Revenue (Q1 FY26)
- ₹3,371 crore
- Net Profit (Q1 FY26)
- ₹664 crore
- Revenue increase
- 11.2%
- Net profit increase
- 21.8%
- US Sales Contribution
- 21%
- India sales (Q1 FY26)
- ₹2,265 crore
- US sales (Q1 FY26)
- ₹698 crore
- International sales (Q1 FY26)
- ₹1,053 crore
- Non-US sales (Q1 FY26)
- ₹355 crore
- Non-US business sales contribution
- 10.7%